SWEDISH ORPHAN BIOVITRUM AB NPV revenue breakdown overview

SWEDISH ORPHAN BIOVITRUM AB NPV revenue for the last year amounted to 22.12 B SEK, the most of which — 13.37 B SEK — came from its highest performing source at the moment, Haematology, the year earlier bringing 10.83 B SEK. The greatest contribution to the revenue figure was made by United States — last year it brought SWEDISH ORPHAN BIOVITRUM AB NPV 8.15 B SEK, and the year before that — 7.36 B SEK.